Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes [Yahoo! F...
Orgenesis Inc. (ORGS)
NASDAQ:AMEX Investor Relations:
orgenesis.com
Company Research
Source: Yahoo! Finance
cell and gene therapies (CGTs), today announced that the Company has been awarded a €1.5 million grant from the Walloon government in Belgium for its EXOFASTTRACK project focused on manufacturing, loading, analytical methods and quality control of therapeutic exosomes. Consortium members include: Orgenesis, Cilyx, CMMI, convExYO, EXO Biologics, ExoXpert, Genflow Biosciences, LiveDrop, ULB, UMONS and Xomexbio. This grant is the second such project awarded to an Orgenesis consortium by the Walloon Government partnership, ATMP-Partenariat d'Innovation Technologique (ATMP-PIT), in collaboration with BioWin, the health cluster of Wallonia, and the Public service of Wallonia. EXOFASTTRACK is a collaborative project focused on accelerating the development of multiple therapeutic exosomes for rapid clinical evaluation. Mainly isolated from stem cells, which are known for their regenerative and anti-inflammatory properties, exosomes are considered to have opened new horizons in cell therapy
Show less
Read more
Impact Snapshot
Event Time:
ORGS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORGS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORGS alerts
High impacting Orgenesis Inc. news events
Weekly update
A roundup of the hottest topics
ORGS
News
- Orgenesis Provides Year End Business Update [Yahoo! Finance]Yahoo! Finance
- Orgenesis Provides Year End Business UpdateGlobeNewswire
- Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility [Yahoo! Finance]Yahoo! Finance
- Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global AccessibilityGlobeNewswire
- Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference [Yahoo! Finance]Yahoo! Finance
ORGS
Sec Filings
- 5/15/24 - Form NT
- 5/6/24 - Form ARS
- 5/6/24 - Form DEFA14A
- ORGS's page on the SEC website